ORMP

Oramed Pharmaceuticals Inc. is an innovative biopharmaceutical company based in New York, focused on advancing diabetes management through its groundbreaking oral drug delivery systems. By developing orally ingestible capsules for polypeptide administration, Oramed aims to enhance patient adherence and improve health outcomes in diabetes care. The company boasts a robust pipeline of therapeutic solutions targeting significant unmet medical needs, positioning it as a potential leader in transforming diabetes treatment and significantly enhancing the quality of life for patients worldwide.